[18F]Fluciclatide PET as a biomarker of response to combination therapy of pazopanib and paclitaxel in platinum-resistant/refractory ovarian cancer

Rohini Sharma, Eric O. Aboagye, Marianna Inglese et al.|European Journal of Nuclear Medicine and Molecular Imaging|2019

Cited by 16